Concord Healthcare's (HKG:2453) controlling shareholder Medstar (Shanghai) Enterprise Management acquired a further 95,400 H shares of the company for HK$641,732, a Monday filing with the Hong Kong bourse said.

The shares, which were purchased from the open market for around HK$6.73 apiece between May 8 and May 9, represent roughly 0.01% of the firm's issued share capital.

Shanghai Medstar previously acquired 45,600 H shares in the Chinese oncology healthcare service provider on May 7.